Download
s12883-020-01903-0.pdf 654,85KB
WeightNameValue
1000 Titel
  • PRediction of acute coronary syndrome in acute ischemic StrokE (PRAISE) – protocol of a prospective, multicenter trial with central reading and predefined endpoints
1000 Autor/in
  1. Nolte, Christian H |
  2. von Rennenberg, Regina |
  3. Litmeier, Simon |
  4. Scheitz, Jan F. |
  5. Leistner, David M. |
  6. Blankenberg, Stephan |
  7. Dichgans, Martin |
  8. Katus, Hugo |
  9. Petzold, Gabor C. |
  10. Pieske, Burkert |
  11. Regitz-Zagrosek, Vera |
  12. Wegscheider, Karl |
  13. Zeiher, Andreas M. |
  14. Landmesser, Ulf |
  15. Endres, Matthias |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-27
1000 Erschienen in
1000 Quellenangabe
  • 20(1):318
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12883-020-01903-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450553/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Current guidelines recommend measurement of troponin in acute ischemic stroke (AIS) patients. In AIS patients, troponin elevation is associated with increased mortality and worse outcome. However, uncertainty remains regarding the underlying pathophysiology of troponin elevation after stroke, particularly regarding diagnostic and therapeutic consequences. Troponin elevation may be caused by coronary artery disease (CAD) and more precisely acute coronary syndrome (ACS). Both have a high prevalence in stroke patients and contribute to poor outcome. Therefore, better diagnostic algorithms are needed to identify those AIS patients likely to have ACS or other manifestations of CAD.!##!Methods/design!#!The primary goal of the 'PRediction of Acute coronary syndrome in acute Ischemic StrokE' (PRAISE) study is to develop a diagnostic algorithm for prediction of ACS in AIS patients. The primary hypothesis will test whether dynamic high-sensitivity troponin levels determined by repeat measurements (i.e., 'rise or fall-pattern') indicate presence of ACS when compared to stable (chronic) troponin elevation. PRAISE is a prospective, multicenter, observational trial with central reading and predefined endpoints guided by a steering committee. Clinical symptoms, troponin levels as well as findings on electrocardiogram, echocardiogram, and coronary angiogram will be recorded and assessed by central academic core laboratories. Diagnosis of ACS will be made by an endpoint adjudication committee. Severe adverse events will be evaluated by a critical event committee. Safety will be judged by a data and safety monitoring board. Follow-up will be conducted at three and twelve months and will record new vascular events (i.e., stroke and myocardial infarction) as well as death, functional and cognitive status. According to sample size calculation, 251 patients have to be included.!##!Discussion!#!PRAISE will prospectively determine the frequency of ACS and characterize cardiac and coronary pathologies in a large, multicenter cohort of AIS patients with troponin elevation. The findings will elucidate the origin of troponin elevation, shed light on its impact on necessary diagnostic procedures and provide data on the safety and diagnostic yield of coronary angiography early after stroke. Thereby, PRAISE will help to refine algorithms and develop guidelines for the cardiac workup in AIS.!##!Trial registration!#!NCT03609385 registered 1st August 2018.
1000 Sacherschließung
lokal Cerebrovascular disease and stroke
lokal Study Protocol
lokal Acute Coronary Syndrome/diagnosis [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Electrocardiography/methods [MeSH]
lokal Troponin/analysis [MeSH]
lokal Stroke/complications [MeSH]
lokal Brain Ischemia/complications [MeSH]
lokal Stroke-heart-syndrome
lokal Coronary Angiography/methods [MeSH]
lokal Acute coronary syndrome
lokal Troponin elevation
lokal Heart-and-brain interaction
lokal Myocardial Infarction/diagnosis [MeSH]
lokal Chronic coronary disease
lokal Biomarkers/analysis [MeSH]
lokal Coronary Artery Disease/diagnosis [MeSH]
lokal Acute ischemic stroke
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-5577-1775|https://frl.publisso.de/adhoc/uri/dm9uIFJlbm5lbmJlcmcsIFJlZ2luYQ==|https://frl.publisso.de/adhoc/uri/TGl0bWVpZXIsIFNpbW9u|https://frl.publisso.de/adhoc/uri/U2NoZWl0eiwgSmFuIEYu|https://frl.publisso.de/adhoc/uri/TGVpc3RuZXIsIERhdmlkIE0u|https://frl.publisso.de/adhoc/uri/QmxhbmtlbmJlcmcsIFN0ZXBoYW4=|https://frl.publisso.de/adhoc/uri/RGljaGdhbnMsIE1hcnRpbg==|https://frl.publisso.de/adhoc/uri/S2F0dXMsIEh1Z28=|https://frl.publisso.de/adhoc/uri/UGV0em9sZCwgR2Fib3IgQy4=|https://frl.publisso.de/adhoc/uri/UGllc2tlLCBCdXJrZXJ0|https://frl.publisso.de/adhoc/uri/UmVnaXR6LVphZ3Jvc2VrLCBWZXJh|https://frl.publisso.de/adhoc/uri/V2Vnc2NoZWlkZXIsIEthcmw=|https://frl.publisso.de/adhoc/uri/WmVpaGVyLCBBbmRyZWFzIE0u|https://frl.publisso.de/adhoc/uri/TGFuZG1lc3NlciwgVWxm|https://frl.publisso.de/adhoc/uri/RW5kcmVzLCBNYXR0aGlhcw==
1000 Hinweis
  • DeepGreen-ID: 5f4ad94b74fb4b2aaee3f23d10ebd930 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6464565.rdf
1000 Erstellt am 2023-11-16T05:11:05.352+0100
1000 Erstellt von 322
1000 beschreibt frl:6464565
1000 Zuletzt bearbeitet 2023-12-01T00:15:43.018+0100
1000 Objekt bearb. Fri Dec 01 00:15:43 CET 2023
1000 Vgl. frl:6464565
1000 Oai Id
  1. oai:frl.publisso.de:frl:6464565 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source